# Protonix Delayed-Release

NDC: 0008-0844
Generic name: PANTOPRAZOLE SODIUM
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20080229

FDA application: NDA022020

## Active ingredients

- PANTOPRAZOLE SODIUM: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0008-0844"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-0844
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08098cb2-c048-4640-f387-6beec4a38936